A
$96.34
Agilent Technologies
($.57)
(.59%)
A
Earnings Whisper ®
N/A
4th Quarter October 2020
Consensus:  $0.91
Revenue:  $1.40 Bil
Tuesday
Nov 17
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when A reports earnings?
Beat
Meet
Miss

Where is A's stock price going from here?
Up
Flat
Down
Stock chart of A
Analysts
Summary of analysts' recommendations for A
Score
Grade
Pivots
Resistance
$98.59
$97.78
$97.06

$96.25

Support
$95.53
$94.72
$94.00
Tweet
Growth
Description
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Peers
IlluminaPerkinElmerTranslate BioCoherentBio-Rad Laboratories